pentobarbital will lower the level or influence of colchicine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

pentobarbital will lessen the level or effect of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers may possibly decrease partiaprevir and ritonavir stages, and as a consequence decreased efficacy of Viekira Pak

pentobarbital will lower the level or impact of fosaprepitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will minimize the level or outcome of docetaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.

pentobarbital will minimize the level or result of doxorubicin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will reduce the level or influence of clarithromycin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.

pentobarbital will minimize the extent or outcome of theophylline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital will lower the extent or effect of dexamethasone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

Therapy should be administered with caution, if in the more info slightest degree, to individuals who're mentally depressed, have suicidal tendencies, or heritage of drug abuse

pentobarbital will lower the level or result of bosentan by affecting hepatic enzyme CYP2C9/ten metabolism. Slight/Significance Not known.

pentobarbital will lower the extent or result of isradipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.

pentobarbital will minimize the level or impact of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

Parenteral methods of barbiturates are remarkably alkaline; Intense treatment should be taken to prevent perivascular extravasation or intra-arterial injection; extravascular injection may possibly cause nearby tissue harm with subsequent necrosis; implications of intra-arterial injection could differ from transient discomfort to gangrene in the limb; any grievance of suffering inside the limb warrants stopping the injection

pentobarbital will decrease the level or influence of sufentanil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.